Interactions between prion protein isoforms: The kiss of death?

Trends in Biochemical Sciences

Volumn 26, Issue 4, 2001, Pages 235-242

  Caughey, Byron ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; GLYCOSYLPHOSPHATIDYLINOSITOL; PRION PROTEIN; PROTEINASE K;

BINDING SITE; BOVINE SPONGIFORM ENCEPHALOPATHY; CARBOXY TERMINAL SEQUENCE; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FATAL FAMILIAL INSOMNIA; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; REVIEW; SCRAPIE; WASTING SYNDROME;

PRION DISEASES; PRIONS; PROTEIN BINDING; PROTEIN ISOFORMS;

BOVINAE;

EID: 0035312586     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(01)01792-3     Document Type: Review

References (42)

1. Prions and neurodegenerative diseases
2. Prions
3. Prion protein and the transmissible spongiform encephalopathies
4. Prion protein interconversions and the transmissible spongiform encephalopathies
5. Self-replication and scrapie
6. Normal host prion protein necessary for scrapie-induced neurotoxicity
7. Signal transduction through prion protein
8. A transmembrane form of the prion protein in neurodegenerative disease
9. A monomer-dimer equilibrium of a cellular prion protein (PrP-C) not observed with recombinant PrP
10. Morphogenesis of amyloid plaques in 87V murine scrapie
11. Three-dimensional structures of prion proteins
12. Biosynthesis and cellular processing of the prion protein
13. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive
14. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions
15. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells
16. Chaperone-supervised conversion of prion protein to its protease-resistant form
17. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state
18. Cell-free formation of protease-resistant prion protein
19. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices
20. Interactions between heterologous forms of prion protein: Binding, inhibition of conversion, and species barriers
21. Protease-resistant prion protein produced in vitro lacks detectable infectivity
22. Prion protein and species barriers in the transmissible spongiform encephalopathies
23. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease
24. Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?
25. Nongenetic propagation of strain-specific phenotypes of scrapie prion protein
26. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy
27. Cellular metabolism of normal and scrapie-associated forms of PrP
28. Strain-specific prion-protein conformation determined by metal ions
29. Aggregates of scrapie associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state
30. Sc dependent cell-free formation of protease-resistant prion protein
31. Cell-lysate conversion of prion protein into its protease-resistant isoform suggests the participation of a cellular chaperone
32. Characterization and polyanion-binding properties of purified recombinant prion protein
33. Interaction of prion proteins with cell surface receptors, molecular chaperones and other molecules
34. A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice
35. Novel therapeutic uses for porphyrins and phthalocyanines in the transmissible spongiform encephalopathies
36. Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible
37. Molecular biology of prion diseases
38. A kinetic model for amyloid formation in the prion diseases: Importance of seeding
39. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides
40. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence
41. Sulfated glycosaminoglycans in amyloid plaques of prion diseases
42. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain